Pfizer Wins Dismissal Of 4 Claims From Celebrex Suit
A federal judge has dismissed a handful of claims from a securities class action against Pfizer Inc. over the company's alleged nondisclosure of studies linking painkillers Celebrex and Bextra to an...To view the full article, register now.
Already a subscriber? Click here to view full article